Likarda Makes Early Phase Discovery Research More Accessible for Everyone

On average, it takes 12 years and $359 million to bring a new drug from the research lab to market–time and money that most science entrepreneurs do not have.

Only five in 5,000 drugs that begin preclinical testing make it to human testing–the odds are against getting a drug to market, especially without the time or money to conduct traditional testing in CROs.

Only one in 5,000 drugs is approved for human usage. Likarda opens the boundaries in research to include those who would otherwise be underserved or refused by research labs, and their discoveries left undiscovered.

Working with science entrepreneurs and partners with contract research organizations and bio consortiums, Likarda provides support for all phases of human and veterinary product development from early discovery through pre-clinical studies.

Our areas of focus are:

  • Pharmaceutical
  • Nutraceutical
  • Supplements
  • Herbal products
  • Cosmetics and hygiene
  • Other health care products

Our services include: